As this July marks the fifth anniversary of the release of preliminary findings of the Women's Health Initiative (WHI), the Society for Women's Health Research will be hosting a panel discussion to facilitate a better understanding of the interpretation of the WHI and its findings.
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), provides comment on the Women's Health Initiative (WHI) Coronary Artery Calcium Study published today in The New England Journal of Medicine (NEJM).
Parents who think their teens' online conversations with their peers are innocent may want to reconsider. A new Caron Treatment Centers qualitative study conducted by Nielsen Buzzmetrics found that 1 in 10 messages analyzed involved teens seeking advice from their peers on how to take illicit drugs "safely" and without getting caught.
New early data showed that an investigational device that specifically targets rapidly growing cancer cells with intermediate frequency electrical fields -- called Tumor-Treating Fields (TTFields) -- more than doubled the median overall survival rates in patients with recurrent glioblastoma multiforme (GBM), the most common and aggressive type of malignant brain tumor. These survival rates observed in the data were compared to historical data.
Today, at the American Museum of Natural History in New York City, Laurent Attal, President and CEO, L'Oréal USA, and Dr. Ralph J. Cicerone, President, National Academy of Sciences, honored the 2007 recipients of the esteemed L'Oréal USA Fellowships For Women in Science.
Data released today show that MR-guided focused ultrasound (MRgFUS) is a more effective option for a broader population of uterine fibroid sufferers. In a poster presented today at the ACOG annual meeting in San Diego, Phyllis Gee showed that women undergoing MRgFUS experience rapid and sustained relief from their condition and have a reduced need for alternative, invasive treatments in the future.
72% of stroke and traumatic brain injury survivors showed improved vision following six months of treatment with NovaVision's Vision Restoration Therapy (VRT).
Today, Almac Diagnostics announced a major study analysing colorectal polyp tissue samples using its novel Colorectal Cancer DSAâ„¢ microarray. The DSAâ„¢ research tool focuses on the transcriptome of an individual disease, in this case colorectal cancer, and contains significant additional data, relevant to the disease of interest that is not available on other generic microarrays.
In light of today's announcement from Edwards' Campaign, Dr. Aman Buzdar is available for media interviews to address breast cancer recurrence.
Berlex, Microsoft, and the National Multiple Sclerosis Society Embark on Landmark Collaboration to Help People with MS Maintain Their Health and Stay Connected
Carbon nanotubes. Bio-medical applications of plants. Medicinal chemistry. The properties of polymers in solution. The self-organizing properties of large molecules. These are the fields of study in which five women scientists have distinguished themselves"”women from five continents who today received the prestigious 2007 L'ORÉAL-UNESCO Award For Women in Science at UNESCO House in Paris, France.
The Kaiser Permanente Northern California Division of Research is launching one of the largest research projects in the United States to examine the genetic and environmental factors that influence common diseases such as heart disease, cancer, diabetes, high blood pressure, Alzheimer's disease, asthma and many others.
AstraZeneca and the American Cancer Society announced a collaboration to significantly extend the reach the ACS Patient Navigator Program, an initiative to assist cancer patients in negotiating the health care system. AstraZeneca has pledged $10 million to help fund 50 new sites over the next five years throughout the U.S. in primarily underserved areas.
Boca Raton Community Hospital will receive the largest gift ever given to a community hospital and the third-largest among all hospitals and health systems in the United States (based upon information from the Advisory Board for the latest year available, 2005) to help build a new academic medical center that will serve as a national model of hospital safety while educating a new generation of medical professionals.
American Heart Association challenges one million women to know their heart disease risk at GoRedForWomen.org! Too few women realize that heart disease is their No. 1 killer and are taking action to prevent it. But the good news is that heart disease can largely be prevented. For that reason, the Go Red For Women movement encourages women to improve their heart health while taking action to fight women's heart disease.
The Global Initiative on Sharing Avian Influenza Data (GISAID) was announced today in a Correspondence letter that appeared online in the journal Nature (http://www.nature.com/nature/journal/vaop/ncurrent/full/442981a.html). The 70 signatories to the Nature letter represent more than 40 countries and include six Nobel laureates. GISAID's policies for rapid and complete data releases are modeled upon those established for other initiatives, such as data on DNA sequence variations in the human genome.
AIDS Vaccine Blueprint 2006 Highlights Important Progress Being Made Against Substantial Challenges, Describes Innovative Ways to Conduct Research and Vaccine Trials, and Supports Stronger Policy Action
The Blueprint includes an assessment of vaccine candidates in the pipeline; highlights key scientific obstacles to the discovery and development of a preventive HIV vaccine; addresses financial and political challenges that are impeding the AIDS vaccine search; and provides new recommendations for overcoming these challenges.
L'Oréal USA announced today the recipients of its esteemed 2006 Fellowships for Women In Science at an awards ceremony at the American Museum of Natural History in New York City. Five young women, all on the cutting-edge of scientific advances, were awarded $20,000 each to carry out research projects.
Go Red for Women's website has been selected as one of the top online destinations for women to visit this summer, according to Michelle Madhok founder of SheFinds.com and widely known online shopping expert. Madhok combed through the Internet in search of the best online deals for the summer and found www.GoRedforWomen.org, which provides a one-stop destination for women to access important heart health information, celebrity stories, recipes and a gift store.
The American Heart Association's Go Red 5 Simple Steps for Women Nationwide To Take Charge of Their Heart Health During Women's Health Week For Women movement is encouraging women to follow 5 simple steps, during National Women's Health Week, to take charge of their heart health. While no time is better than the present, women can begin this new and improved lifestyle while preparing for the summer months.
Media Teleconference date/time changed to 1 p.m. to 2:30 p.m. TODAY to Discuss Embargoed Results of Largest Study to Examine Effects of Third-Party Prayer. Because the AHJ is no longer enforcing the Tuesday embargo, the study authors will conduct a media teleconference today, rather than original date/time of April 3, 10-11:30 AM.
On Tuesday, April 4, the American Heart Journal will publish the results of the Study of the Therapeutic Effects of Intercessory Prayer (STEP), the largest study to examine the effects of intercessory prayer. The STEP research team evaluated the impact of such prayer on patients recovering from coronary artery bypass graft surgery.
The American Skin Association (ASA) announced today that it has granted its 2006 Research Scholar Awards to four promising investigators conducting research in the causes, prevention and treatment of skin diseases and cancers.
This April is the 20th Annual Alcohol Awareness Month, which is an opportunity to spotlight the millions of girls and women who suffer from addiction. So many of them are left untreated each year because they are ashamed of their disease or their doctors and loved ones don't recognize the signs of addiction.
AstraZeneca, the University of Miami and Humana Innovation Enterprises announce the creation of a multi-year research collaboration to improve consumer health by addressing the growing nationwide problem of patients not taking their prescribed medication or getting the treatment they need for chronic health problems.
MGI PHARMA, INC. today announced the publication of long-term (56 month) follow-up data showing that Gliadel® Wafer provides a durable long-term survival benefit for patients with high-grade malignant glioma.
Today at UNESCO House in Paris, Sir Lindsay Owen-Jones, Chairman and CEO of L'ORÉAL, and Koïchiro Matsuura, Director-General of UNESCO, presented the prestigious 2006 L'ORÉAL-UNESCO For Women in Science prize to five distinguished women scientists from North America, Africa, Asia/Pacific, Europe, and Latin America.
The U.S. Food and Drug Administration today approved an innovative combination of technologies - the Niobe(r) Magnetic Navigation System and the CARTOâ„¢ RMT System - that will enhance a doctors' ability to treat patients with cardiac arrhythmias.
Although premature infants are at increased risk of hospitalization due to respiratory syncytial virus (RSV), nearly one half of parents of premature infants are not aware of preventive medicine that can help protect their babies from RSV, according to a recent Internet survey.
Tercica, Inc. (Nasdaq:TRCA) today announced the U.S. commercial launch of Increlex(TM) (mecasermin (rDNA origin) injection), the only recombinant human insulin-like growth factor-1 (rhIGF-1) replacement therapy indicated for the long-term treatment of growth failure in children with severe Primary IGFD.
New data from a Spanish study found that patients with bifurcation lesions fared significantly better when treated with the CYPHER(r) Stent compared with the Taxus stent in the areas of late loss, re-treatment and re-blockage (restenosis).
During virus season premature babies are at a higher risk of developing RSV. In New York, there are more than 18,000 premature births each year. As these numbers continue to rise, safeguarding preemies' lung health during virus season becomes crucial.
Merck & Co., Inc. announced today that the Company submitted a Biologics License Application (BLA) for GARDASIL® (quadrivalent human papillomavirus types 6, 11, 16, 18, recombinant vaccine) to the U.S. Food and Drug Administration (FDA) on December 1, 2005.
The Lesbian, Gay, Bisexual and Transgender (LGBT) Health, Education and Research Trust (LGBT HEART) today announced the first two recipients of the LGBT HEART Scholarship Fund for the Health Sciences. Each received $2,000 scholarships for the current academic year.
November is Premature Awareness Month. More than 500,000 premature infants are born each year in the United States, approximately one every 60 seconds. Underdeveloped lungs and weak immune systems leave these fragile patients susceptible to respiratory illnesses.
Preliminary three-year data from the SAPPHIRE and final three-year data from the U.S. Carotid Feasibility Study demonstrate the long-term durability of carotid artery stenting for the prevention of stroke versus carotid endarterectomy in high risk surgical patients.
Results from a study on chronic total occlusions in the coronary arteries show positive clinical outcomes in patients treated with the CYPHER(r) Stent compared to those treated with conventional bare metal stents.
Results from the SISR trial, a study of the CYPHER(r) Stent versus brachytherapy in patients with bare-metal in-stent restenosis, were presented today at TCT. Patients who received the CYPHER(r) Stent had a significantly lower incidence of target vessel failure at nine months post-procedure.
Biosense Webster, Inc. today announced that the company has received clearance by the U.S. FDA for devices that aid electroanatomical mapping. The products were all designed to integrate with the Niobe(r) Magnetic Navigation System designed by Stereotaxis, Inc.
At a news briefing today, neonatal experts urged pediatricians and parents to take action to protect premature babies during the upcoming virus season, which begins in October and lasts through April"”and in some parts of the country, beyond then.
More than 500,000 premature infants are born each year in the United States, approximately one every 60 seconds. Underdeveloped lungs and weak immune systems leave these fragile patients susceptible to respiratory illnesses.
Clinical experts from Children's Hospital Boston and the National Association of Neonatal Nurses lead media teleconference to review data and offer advice on safeguarding preemie health.
Noted endocrinologist, Marc Sandberg, MD, is available to answer questions and talk with reporters about the implications of inhaled insulin in the context of the current state-of-the-art insulin delivery technologies.
Tercica, Inc. announced today that the FDA has approved Increlex(TM) for the long-term treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with growth hormone (GH) gene deletion who have developed neutralizing antibodies to growth hormone.
A review article examines the need for established treatment guidelines to support doctors and nurses in correctly dosing and administering intravenous immunoglobulin as replacement therapy in patients with primary immunodeficiency disorders, who do not produce adequate levels of antibodies essential in fighting infectious diseases.
New research shows that a naturally-produced protein, KDI tri-peptide, can block the damaging effects of glutamate, a substance that is released by the body in response to CNS trauma and neurodegenerative disorders.
The 2005 U.S. News & World Report's "America's Best Hospitals" issue has ranked New York City's Hospital for Special Surgery (HSS) No. 2 in orthopedics and No. 3 in rheumatology.
To mark the start of Heart Health Month, The Larry King Cardiac Foundation is hosting a media briefing focused on the "Changing Face of Cardiovascular Disease" and how current research is helping more patients understand the various treatment options available.
Approximately 36 million uninsured Americans will be eligible to receive meaningful savings on a wide range of brand-name and generic prescription products through the Together Rx Access Card program, launched today by 10 companies.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right